Diacyl glycerols and phorbol esters, which activate protein kinases C, stimulated Ehrlich ascites tumor cell ferricyanide reductase activity. On the contrary, selective inhibition of active protein kinases C with bis-indolyl maleimide did not change the rate of ferricyanide reduction by E]~rlich cells. Selective inhibitors of phosphoprotein phosphatases, okadaic acid and cyclosporin A, also stimulated plasma membrane redox system. Taking all these data together, protein kinases or phosphoprotein phosphatases seemed to be involved in the multiple and complex regulation of Ehrlich cell plasma membrane redox system.
Introduction
Plasma membrane redox systems (PMRS) have been found out to be ubiquitous ( [1, 2] and references therein). PMRS have been related I:o several vital functions, including energization of organic solute transport and control of cell growth [3, 1] . In our lab, a plasma membrane ferricyanide reductase activity has been studied in whole Ehrlich ascites tumor cells [4, 5] , in native plasma membrane vesicles [6] [7] [8] , and in reconstituted proteoliposomes [9] , and very recently it has been purified to apparent homogeneity [10] . Once fulfilled the molecular approach to the study of PMRS, we decided to go back to the regulation of PMRS in whole cells. Since PMRS seems to play a role in growth control, it has to be somehow integrated in the sequence of events leading to the modulation of cell growth by both external and internal signals. In fact, hormones and growth factors have been demonstrated to modulate PMRS activity [1, 11] . Further, N-myc and Ha-ras oncogene expressions seem to correlate with PMRS activity [11, 12] . Recently, PMRS has been related to the ras signaling pathway [ 12, 13] , and cAMP and heterotrimeric G proteins have been demonstrated to be involved in the regulation of PMRS [14, 15] . Despite of all this fragmentary information, to our knowledge no comprehensive approach to the study of the involvement of different signal transduction pathways in the control of PMRS activities has been carried out up to now. In an effort to cover this gap, we have postulated that Ehrlich cell PMRS should be controlled by a complex and multiple mechanism involving different signal transduction pathways and we have begun to test this postulate. In fact, we have recently reported that cGMP and Ca 2+ are two second messenger involved in the modulation of Ehrlich cell PMRS activity [16] . We have also obtained evidence for the involvement of cytoplasmic pH as a modulator of Ehrlich cell PMRS activity (unpublished data). In this report, we support evidence for the involvement of protein kinases C and phosphoprotein phosphatases in the regulation of Ehrlich cell PMRS.
Materials and methods

Cells
cells were harvested in the plateau phase of growth (9-11 days after tumor inoculation), and they were washed and suspended in PBS, without or with 5 mM glucose added as the only substrate for long-term (up to 8 h) survival of harvested cells, as demonstrated by P&ez-Rodrfguez et al. [18] .
Ferricyanide reductase assay in whole cells
A discontinuous assay was carried out with 5 × 10 7 cells/ml in the presence of 0.5 mM ferricyanide, as previously described [4] .
Treatments
B Preincubation of 107 cells/ml were carried out during different times, as follows: 20 min for cyclosporin A; and 30 min for the rest of products tested. In all cases, the concentrations used were similar to those described in the biochemical literature which have shown the maximum effect. All the experiments were carried out with parallel controls in which the different drugs were omitted. After preincubation, cells were washed twice and suspended in PBS to carry out ferricyanide reductase assay as described above.
Results and discussion
The involvement of PMRS in important vital functions points to its role as a target of different biochemical signals. Thus, PMRS can be involved in downstream second messenger function by direct action on cytosolic components or by modification of other membrane enzymes directly involved in messenger formation [19] . In this context, PMRS has been shown to activate certain protein kinases C [20] . On the other hand, PMRS seems to respond to upstream modulatory signals. The modulatory effects of extracellular signals, namely, hormones and growth factors on PMRS are well documented [1, 11, 21, 22] . Much less is known concerning the role of intracellular signals and signal transducers on the modulation of PMRS activity. Ehrlich cells have proven to be a convenient model for these studies [16] .
Several clues seem to indicate a role for certain protein kinases C in the control of PMRS. In fact, incubation of Ehrlich cells with the cell-permeable diacyl glycerol, sn-1,2-dioctanoyl glycerol [23] , at 3 ~M final concentration produced a high increase in ferricyanide reductase activity (results not shown). Furthermore, a stimulation of this activity could also be detected upon incubation of Ehrlich cells with PMA, a phorbol ester that can substitute for diacyl glycerols and mimic their effect on protein kinases C [24] . As shown in Fig. 1A selective inhibitor of protein kinases C [25] , produced no significant change in ferricyanide reductase activity, as compared with the values in the respective control experiments (see Fig. 1B ). The picture that seems to emerge from these data is that PMRS could be stimulated by the activation of those protein kinases C commonly inactive; on the contrary, PMRS would not be sensitive to those protein kinases C which are active in the control situation. Taking into account the data shown by Malviya and Anglard [20] , it seems that PMRS and protein kinases C mutually modulate each other. It could be expected that phosphoprotein phosphatase inhibition would provide new arguments for the role attributed to protein phosphorylation in controling PMRS activity. In fact, the tumor promoter okadaic acid is a potent inhibitor of PP-2A [26, 27] . On the other hand, the immunosuppressor cyclosporin A has been also described as a potent and selective inhibitor of PP-2B [28] . Data in Fig. 2A and 2B indicate that inhibition of active phosphoprotein phosphatases 2A and 2B produces a significant increase in Ehrlich cell PMRS activity. Data obtained with okadaic acid and PMA could have a second explanation, not necessarily incompatible with the first ones: both compounds would activate MAP kinases indirectly, as suggested by G6mez and Cohen [29] .
It is noteworthy to keep in mind that previously published reports suggest a possible involvement of protein kinases A and tyrosine kinases in the control of certain PMRS activities [14, 30] .
The use of activators and inhibitors of intermediary steps in a signal transduction pathway can clarify the role of these steps in the sequence of events leading to a concrete response. Though no individual result can be considered as a conclusive evidence for the involvement of certain signal transduction pathways, the cummulative and coincident results shown here offer a congruent and consistent picture of a very complex and tightly regulated process. According to the key roles that seems to play in cell physiology, PMRS should be expected to be accurately regulated by more than one regulatory pathway. In fact, this is the main conclusion that could be obtained from the data given in this report. Many efforts remain to be done in order to elucidate the actual involvement of different signal transduction pathways in the control of PMRS, as well as to determine with accuracy the sequence of events upstream and downstream of the PMRS.
Finally, a consideration should be given to the fact that our results have been obtained in a model system that is a transformed, neoplastic cell. This fact raises the question whether similar mechanisms of control operate on PMRS of normal, non-transformed cells. In this context, it is noteworthy to note that Garcfa Cafiero [31] has reported that cultured normal liver cells do not respond to PMA but their PMRS is inhibited by H-7, a protein kinase C inhibitor.
